Michelangelo Foundation

The Michelangelo Foundation is an independent, non-profit research organization based in Milan, Italy, specializing in the design and management of international clinical trials in oncology. The foundation focuses on advancing personalized medicine and innovative therapeutic strategies, particularly for breast cancer and other solid tumors. It serves as a bridge between academic research and clinical practice, collaborating with global pharmaceutical companies and medical institutions to conduct high-impact Phase 2 and Phase 3 studies. Notable for its leadership in landmark trials such as NeoALTTO and NeoSphere, the foundation has significantly contributed to the development of HER2-targeted therapies. Its activities encompass scientific coordination, data analysis, and the promotion of translational research to improve patient outcomes.